SPOTLIGHT -
April 17th 2024
What are the most effective approaches to SUD treatment in this unique patient population?
Explore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.
April 15th 2024
How can telehealth aid in the treatment of opioid use disorders in this patient population?
April 11th 2024
Take a look back at our recent coverage relating to our April content theme.
April 1st 2024
Write to us now to be part of our series focused on addiction and substance use disorders this month.
Adherence in Addiction Recovery Treatment: Surrender is Scary, Yet Critical
Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.
Read More
The Week in Review: May 29-June 2
From substance use among adolescents and young adults to managing behavioral and psychological symptoms of dementia, here are highlights from the week in Psychiatric Times.
Substance Use Among Adolescents and Young Adults
In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.
Teach and Treat Your Children Well
"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."
Everything You Need to Know When Referring Patients to Ketamine Therapy Clinics
Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?
The Week in Review: May 1-5
From new FDA treatment approvals to choosing the right levels of care in crisis stabilization units, here are highlights from the week in Psychiatric Times.
An Imperfect Guide to Crisis Stabilization Units: Matching the Right Level of Care to Individual Needs
Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.
From the Pages of Psychiatric Times: April 2023
The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.
The Week in Review: April 10-14
From to co-occurring substance use and eating disorders to treatment options for OCD, here are highlights from the week in Psychiatric Times.
New SAMHSA CCBHC Criteria Will Foster Innovation in Crisis Services Continuum
The new criteria have been updated to increase flexibility and provide greater clarity around standards for behavioral health clinicians.
Co-occurring Substance Use and Eating Disorders
What does existing research say about the connection between substance use disorders and eating disorders?
The Week in Review: April 3-7
From over-the-counter naloxone to the true connection between gun violence and mental illness, here are highlights from the week in Psychiatric Times.
Over-the-Counter Naloxone: A Step in the Right Direction?
Psychiatric Times’ Substance Use Section Editor weighs in on the FDA approval of the first naloxone product for nonprescription use.
The Week in Review: March 27-31
From gut microbiota and SSRIs in MDD to nonpharmacological interventions following TBI, here are highlights from the week in Psychiatric Times.
FDA Approves First Naloxone Product for Over-the-Counter Use
The AMA, substance abuse experts share their thoughts on this decision and what it means for psychiatric clinicians and their patients.
Thoughts About the Overdose Conundrum
One doctor’s experience with patient suicide.
The “Unwinding” of the Medicaid Continuous Enrollment Condition: 3 Things to Know
Patients with serious mental illness and substance use disorders are expected to be particularly affected by these changes.
The Week in Review: February 6-10
From the impact of patients’ overdose deaths on physicians to addressing America’s mental health crisis, here are highlights from the week in Psychiatric Times.
The Overdose Conundrum
A patient loss does not undo or discard the multitude of meaningful life changing and life preserving work done.
The Year in CMEs
Revisiting the CME articles featured in Psychiatric Times in 2022.
Current Treatments for Cannabis Use Disorder
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Drug Abuse Trends and Treatment Approaches for 2023
What are the most pertinent drug trends to be aware of in 2023?
Assessing 2022: What’s the Prognosis in Psychiatry?
The Road to Over-the-Counter Naloxone: FDA Releases Federal Register Notice
We may be one step closer to nonprescription naloxone.
COVID-19 and Mental Health: Global Consequences and CAM Approaches
In this CME article, explore the mental health consequences associated with the COVID-19 pandemic as well as the potential role for complementary and alternative approaches.
Clinicians Embracing a Recovery Mindset: Mirroring Recovery to People You Serve
What is recovery?
The Week in Review: October 10-14
From traumatic brain injury to the dangers of excessive social media usage, here are highlights from the week in Psychiatric Times.
Understanding the Long-Term Clinical Course of Comorbid SUD and ADHD
Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?
Expert Sheds Light on Opioid Overdose Crisis in Youth
Opioid use, addiction, and overdose in youth continue to increase. What can be done?
From the Pages of Psychiatric Times: September 2022
The experts weighed in on a wide variety of psychiatric issues for the September 2022 issue of Psychiatric Times.